REQUEST A DEMO
Total
USD $0.00
Search more companies

Apipharma Bis Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Basic Inorganic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Wholesale Trade Agents and Brokers | Other Activities Related to Credit Intermediation
Full name: Apipharma Bis Sp. z o.o. Profile Updated: December 15, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Apipharma Bis Sp. z o.o. is based in Poland, with the head office in Katowice. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. Apipharma Bis Sp. z o.o. was incorporated on February 12, 2016. A negative growth of 27.81% was recorded in its total assets.

Headquarters
Ul. Tadeusza Kosciuszki 44/7
Katowice; Slaskie; Postal Code: 40-040

Contact Details: Purchase the Apipharma Bis Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Apipharma Bis Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Apipharma Bis Sp. z o.o. report to view the information.
Incorporation Date:
February 12, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apipharma Bis Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
70.89%
EBITDA
70.89%
Net Profit/Loss for the Period
62.05%
Total Assets
-27.81%
Total Equity
-29.59%
Return on Equity (ROE)
35.95%
Quick Ratio
-3.89%
Cash Ratio
-4.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?